Try our Advanced Search for more refined results
Astellas Pharma Inc.
-
Misc | Filed: June 06, 2024 | Entered: June 06, 2024 Astellas Pharma Inc. et al v. Sandoz Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Redacted Document
REDACTED VERSION of 606 Answering Brief in Opposition, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra)
-
Appeal | Filed: June 05, 2024 | Entered: June 06, 2024 Astellas Pharma Inc. et al v. Lupin Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
USCA Order Terminating Appeal
USCA Order Terminating Appeal as to 211 Notice of Appeal (Federal Circuit), filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. USCA Decision: The proceeding is DISMISSED under Fed. R. App. P. 42 (b). Each side shall bear their own costs. (jfm)
-
Discovery | Filed: June 05, 2024 | Entered: June 05, 2024 Astellas Pharma Inc. et al v. Lupin Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login